Biotechnology Companies By Peg Ratio
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Earnings To Growth
| Price To Earnings To Growth | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | SRPT | Sarepta Therapeutics | (0.15) | 4.38 | (0.66) | ||
| 2 | IONS | Ionis Pharmaceuticals | (0.04) | 2.58 | (0.11) | ||
| 3 | MEIP | MEI Pharma | 0.01 | 1.94 | 0.01 | ||
| 4 | ZVRA | Zevra Therapeutics | (0.01) | 2.79 | (0.04) | ||
| 5 | ASND | Ascendis Pharma AS | 0.11 | 3.41 | 0.37 | ||
| 6 | XRTX | XORTX Therapeutics | 0.00 | 6.05 | (0.03) | ||
| 7 | BIIB | Biogen Inc | (0.04) | 1.70 | (0.07) | ||
| 8 | ORGO | Organogenesis Holdings | 0.11 | 13.99 | 1.51 | ||
| 9 | ANIK | Anika Therapeutics | (0.03) | 2.11 | (0.07) | ||
| 10 | IMAB | I Mab | 0.00 | 4.11 | 0.01 | ||
| 11 | IBRX | Immunitybio | 0.05 | 6.38 | 0.32 | ||
| 12 | LFCR | Lifecore Biomedical | (0.04) | 3.98 | (0.15) | ||
| 13 | STRR | Star Equity Holdings | 0.13 | 3.63 | 0.47 | ||
| 14 | EVO | Evotec SE ADR | (0.15) | 3.08 | (0.48) | ||
| 15 | IMTX | Immatics NV | (0.14) | 3.63 | (0.50) | ||
| 16 | MDXG | MiMedx Group | (0.10) | 1.79 | (0.18) | ||
| 17 | EXEL | Exelixis | 0.09 | 2.40 | 0.21 | ||
| 18 | ABCL | Abcellera Biologics | (0.02) | 4.67 | (0.11) | ||
| 19 | RGC | Regencell Bioscience Holdings | 0.18 | 33.09 | 6.10 | ||
| 20 | HLN | Haleon plc | 0.05 | 1.44 | 0.08 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth. Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.